Bulls N' Bears with Matt BirneyAmplia Therapeutics: An oral cancer drug trial with serious results!
Listen to ASX-listed Amplia Therapeutics Managing Director Chris Burns talk to Matt Birney on the Bulls N’ Bears Report about Amplia’s remarkable drug that looks to be having an impact on a known cancer growth protein.
In 1 playlist(s)
Bulls N' Bears with Matt Birney
Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Per…Social links
Follow podcast
Recent clips
Chariot Resources: Massive lithium grades, a big Chinese cheque book and an ASX company
03:07
Great Southern Mining: It goes deep – Laverton gold play grows serious legs!
03:04
Elk Range Mining IPO: This US gold project is anything BUT Greenfields!
03:05